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Background: Ethnomedicinally Rumex hastatus D. Don has been used since long for various ailments especially in
neurological disorders. The reported data and the importance of Rumex genus demonstrate the vital medicinal
value of R. hastatus.
Methods: In the current investigational study, isolation of essential oil and its antioxidant and anticholinesterase
assays were performed. The essential oil of R. hastatus was analyzed by GC-MS for the first time. The essential oil
was evaluated for anticholinesterase and antioxidant assays. The anticholinesterase assay was conducted at various
concentrations (62.5 to 1000 μg/ml) against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Similarly,
the antioxidant potential was determined using DPPH and ABTS free radicals.
Results: The GC-MS analysis of essential oil showed 123 components. The result recorded for the anticholinesterase
assays demonstrated a marked potential against AChE and BChE with IC50 values of 32.54 and 97.38 μg/ml respectively
which were comparable with the positive control i.e., galanthamine (AChE, IC50 = 4.73 μg/ml and BChE, IC50 = 11.09 μg/
ml). The antioxidant assays against DPPH and ABTS free radicals also exhibited significant scavenging potential
with IC50 values of 3.71 and 6.29 μg/ml respectively, while for ascorbic acid the IC50 value was <0.1 μg/ml against
both free radicals.
Conclusions: Based on the current investigational studies, it may be concluded that R. hastatus is an effective
source of essential oil's components having anticholinesterase and antioxidant potentials, which after subjecting
to drug development may lead to novel drug candidates against neurodegenerative disorders.
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hastatusBackground
A brief history of medicine demonstrates the use of
herbal medicine for the effective treatment of various
ailments. Herbal medicine has been used since long in
various forms including the decoction, powdered sample,
oleoresins, crude extracts, fixed oil, essential oil etc [1].
Various plants have been used in multiple types of food* Correspondence: farhataziz80@hotmail.com
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regards, essential oils have been manifested by several
reporters to play a major role. Essential oils have the
property to attenuate the effects of free radicals, e.g, re-
active oxygen species (ROS) which are derived from me-
tabolism of oxygen and exogenous agents [3]. ROS are
responsible for wide variety of diseased conditions in-
cluding oxidative stress and nervous disorders [4]. Es-
sential oils are well-known for their radicals scavenging
properties and amelioration of various cognitive disor-
ders. Among the cognitive disorders, Alzheimer’s diseaseis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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the best therapeutic approaches for AD is to increase
the concentration of the neurotransmitter (Acetylcho-
line) by inhibiting the enzyme (acetylcholinesterase) re-
sponsible for its breakdown. Various drugs originated
either from natural or synthetic sources are being used
for the management of AD and other nervous disorders
[6]. Similarly, it has also been reported that oxidative
stress are responsible for wide variety of mental diseases
due to neuronal degeneration and other factors. Oxida-
tive stress is mainly developed due to increase in con-
centration of free radicals within the body. The free
radicals have been reported by numerous researchers to
possess multiple destructive properties, due to which
interest has been focused to scavenge the free radicals
somehow and avoid their deteriorating effects [7]. In this
context, investigators are trying to explore more and
more sources of natural and synthetic bioactive princi-
ples [8]. The natural drugs are being preferred over the
synthetic due to their negligible harmful and deleterious
effects [9]. That’s why researchers are trying to explore
novel sources of natural medicine [10–18]. Among the
natural sources, herbal medicines have been shown
promising results due to the presence of numerous sec-
ondary metabolites and essential oils. Essential oils iso-
lated from various plants have been reported to possess
marked acetylcholinesterase inhibitory and radicals scav-
enging potential [19–21]. Traditional knowledge also
demonstrates the use of essential oils for various ner-
vous system disorders [22].
R. hastatus D. Don belongs to the family Polygona-
ceae. Various members of this family have been reported
to be used against paralysis, headache and other nervous
system disorders [23–26]. Various solvent samples of R.
hastatus have recently been reported to possess strong
anticholinesterase and antioxidant potentials [26]. To
date, the chemical composition of essential oil of R. has-
tatus has not been reported or evaluated for any
pharmacological activity. Based on the literature survey
and medicinal importance of R. hastatus, the current in-
vestigational study is arranged to isolate the essential oil,
analyze the chemical composition and to evaluate for
the anticholinesterase and antioxidant potentials, which




The aerial parts of R. hastatus were collected from the
proximity of University of Malakand. The plant was iden-
tified by plant taxonomist Ali Hazrat and deposited with
voucher number (1015SJ) in the herbarium of Department
of Botany, Shaheed Benazir Bhutto University Sheringal,
Dir (U), KPK, Pakistan. Extraction of essential oil of R.hastatus was performed by hydrodistillation using cleven-
ger type apparatus [27]. The essential oil obtained was
stored at -20 °C until required.
Chemicals and drugs
DPPH (Sigma Aldrich CHEMIE GmbH USA, code
101341986), K2S2O4 (Riedel-de Haen Germany), ABTS
(Sigma Aldrich USA, code 1001551916), Gallic acid
(GmbH USA), Folin Ciocalteu reagent (Merck Co.
Germany). AChE (Electric eel type-VI-S, Sigma-Aldrich
GmbH USA, code 1001596210), BChE (Equine serum
Lyophilized Sigma-Aldrich GmbH USA, code 101292670),
Acetylthiocholine iodide (Sigma-Aldrich UK, code
101303874), Butyrylthiocholine Iodide (Sigma-Aldrich
Switzerland, code 101334643), DTNB (Sigma-Aldrich
Germany, code 101261619), Galanthamine hydrobro-
mide Lycoris Sp. (Sigma-Aldrich France, code G1660).
K2HPO4, KH2PO4, KOH. All the chemical used were of
analytical grade.
Gas Chromatography (GC) analysis
The GC analysis of essential oil was carried out via gas
chromatograph Agilent USB-393752 (Agilent Technolo-
gies, Palo Alto, CA, USA) with HHP-5MS 5 % phenyl-
methyl siloxane capillary column (30 m × 0.25 mm ×
0.25 μm film thickness; Restek, Bellefonte, PA) con-
nected with FID detector. The oven was set at
temperature of 70 °C for one minute and then increased
to 180 °C at the rate of 6 °C/min for 5 min and lastly to
280 °C at the rate of 5 °C/min for 20 min. The
temperature of injector and detector were maintained at
220 °C and 290 °C correspondingly. The flow rate of car-
rier gas i.e., Helium was 1 ml/min and the diluted sam-
ples (1/1000 in n-pentane, v/v) of 1 μl were manually
injected in the split-less mode.
Gas Chromatography–Mass Spectrometry (GC-MS)
analysis
The GC/MS of the essential oil was performed via
USB-393752 gas chromatograph (Agilent Technologies,
Palo Alto, CA, USA) with a HHP-5MS 5 % phenyl-
methyl siloxane capillary column (30 m × 0.25 mm ×
0.25 μm film thickness; Restek, Bellefonte, PA) outfitted
with an Agilent HP-5973 mass selective detector in the
electron impact mode (Ionization energy: 70 eV) work-
ing under the experimental conditions as those main-
tained for GC.
Identification of components
The recognition of all the major constituents of oil was
performed by comparing their retention times with the
authentic compounds in the literature. Identification of
compounds was further processed through the spectral
data obtained from the Wiley and NIST libraries as well
Table 1 Anticholinesterase activity of essential oil of Rumex hastatus at various concentrations
Samples Enzymes Conc. μg/ml Conc. μg/ml Conc. μg/ml Conc. μg/ml Conc. μg/ml IC50 μg/
ml62.5 125 250 500 1000
EO AChE 54.32 ± 1.33 61.64 ± 1.60 67.26 ± 1.24 71.70 ± 1.63 74.90 ± 0.52 32.54
EO BChE 46.32 ± 3.50 52.73 ± 0.78 57.00 ± 2.80 66.33 ± 0.49 71.32 ± 4.8 97.38
Gal AChE 72.08 ± 1.04 78.58 ± 1.12 83.70 ± 1.60 89.00 ± 1.15 96.65 ± 1.34 04.73
Gal BChE 66.87 ± 1.27 73.67 ± 0.88 79.95 ± 2.01 86.62 ± 1.67 91.61 ± 0.43 11.09
Data is expressed as Mean ± SEM; EO and Gal are abbreviated for Essential oil and Galanthamine respectively
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spectra with data reported in literature or with those of
mass spectra from literature [28, 29]. Each determin-
ation was processed in duplicate.Anticholinesterase assays
Anticholinesterase (AChE and BChE inhibitions) activity
was performed for the essential oil of R. hastatus by
spectrophotometric analysis following the method of Ell-
man's assay [30]. The substrates used were acetylthio-
choline iodide and butyrylthiocholine iodide. Briefly,
5 μL of 0.03 U/mL AChE and 0.01 U/mL BChE were
taken in a cuvette and 205 μL of essential oil having con-
centration of 62.5–1000 μg/mL were transferred to them
using micropipette. Similarly, 5 μLof DTNB was also
added to this afterwards. The mixtures obtained were
kept in water bath for 15 min at the temperature of
30 °C. After incubation, 5 μL of the Substrates were
added to the mixture to optimize the reaction. A
double beam spectrophotometer was used to measure
the reaction time at 412 nm via a double beam spec-
trophotometer (Thermo electron corporation USA).
Absorption values were obtained for 4 min. Mean-
while, the yellow colored mixtures indicated the for-
mation of 5-thio-2-nitrobenzoate anion as a reaction
product of thiocholines and DTNB. White assay wasTable 2 Parameters of various components of essential oil of Rumex
RT (min) Height Height (%) Area
6.447 254413 18.51 620057
6.818 324110 23.59 626045
10.958 430958 31.36 822529
11.363 250143 18.2 592697
11.761 278058 20.23 665761
12.97 177060 12.88 399792
13.171 312841 22.77 664487
13.308 1E + 06 100 3E + 06
15.063 159790 11.63 336861
19.213 450356 32.77 782083also performed without enzymes and plant samples to
check the non-enzymatic hydrolysis of substrate. The
mixture which contained all the components exclud-
ing essential oil was marked as control. Percent en-




% enzyme activity ¼ V
Vmax
 100
% enzyme inhibition ¼ 100−% enzyme activity
(Where V symbolizes the rate of reaction in the pres-
ence of inhibitor and Vmax stands for rate of reaction
without inhibitor)
DPPH radical scavenging assay
The DPPH radical scavenging potential was evaluated
for essential oil of R. hastatus following previously
described procedure [31]. DPPH solution (0.004 %)
was prepared in methanol to get a deep violet colored
solution. Similarly, stock solution of essential oil was
prepared in ethanol having concentration of 1 mg/
mL. The stock solution was serially diluted to get the
concentrations of 62.5 to 1000 μg/mL. Afterwards,hastatus
Area (%) Area Sum % Base Peak m/z Width
20.82 5.87 83 0.127
21.02 5.93 57.1 0.077
27.61 7.79 55.1 0.074
19.9 5.61 59.1 0.09
22.35 6.31 59.1 0.094
13.42 3.79 43.1 0.097
22.31 6.29 55.1 0.08
100 28.21 57.1 0.1
11.31 3.19 55.1 0.08
26.26 7.41 133.1 0.064
Table 3 List of components of essential oil of Rumexhastatus
S.No Compound Label Common name RT Formula Hits (DB)
1. Trans-dideuterioxy-cyclopentene NF 5.757 C5H6D2O2 10
2. 1-Nonen-4-ol NF 5.884 C9H18O 10
3. Ethyl 2-hydroxybutyrate NF 6.169 C6H12O3 10
4. 2(5H)-Furanone, 5-ethyl NF 6.445 C6H8O2 10
5. Pentanoic acid, 4-oxo Levulinic acid 6.68 C5H8O3 10
6. 2,2-Dimethylpropanoic anhydride Trimethylacetic anhydride 6.819 C10H18O3 10
7. Heptanoic acid Enanthic acid 7.117 C7H14O2 10
8. Ethanethioic acid, S-(2-methylpropyl) ester NF 7.374 C6H12OS 10
9. 4-Octanol, 7-methyl NF 7.511 C9H20O 10
10. 4-(Tetrahydrofuranyl-2-oxy)-4-methyl-2-pentanone NF 7.619 C10H18O3 10
11. Cyclopropane, 1,2-dimethyl-1-pentyl NF 7.698 C10H20 10
12. n-Nonanal Nonanal 7.852 C9H18O 10
13. Cyclooctanone NF 8.275 C8H14O 10
14. 1,4,4-Trimethylcyclohexa-2-en-1-ol NF 8.494 C9H16O 10
15. 3-Octanol, 2-methyl NF 8.716 C9H20O 10
16. 2-Oxatricyclo[3.3.1.1(3,7)]decane, 1-methyl- NF 9.116 C10H16O 10
17. Succinimide, N-methoxy NF 9.338 C5H7NO3 10
18. 4-Heptanol, 2-methyl NF 9.547 C8H18O 10
19. Ethanone, 1-(methylphenyl) Methylacetophenone 9.712 C9H10O 10
20. Decanal NF 10.099 C10H20O 10
21. 3-Heptanol, 2,4-dimethyl NF 10.328 C9H20O 10
22. Cyclooctanone NF 10.957 C8H14O 10
23. 1-Decyne (CAS) $$ Octylacetylene NF 11.165 C10H18 10
24. 3-Heptanol, 5-methyl NF 11.364 C8H18O 10
25. Nonanoic acid Pelargic acid 11.456 C9H18O2 10
26. ETHYL AMYL CARBINOL NF 11.763 C8H18O 10
27. CIS-SABINENE HYDRATE NF 11.96 C10H18O 10
28. 1,8-Bisoxiranylnonane NF 12.047 C13H24O2 10
29. 3-Heptanone, 4-methyl NF 12.817 C8H16O 10
30. Methyl 2-vinylbutanoate NF 12.972 C7H12O2 10
31. trans-3-Nonen-2-one NF 13.171 C9H16O 10
32. Octane, 2,4,6-trimethyl NF 13.309 C11H24 10
33. 2H-Pyran-2-one, 6-heptyltetrahydro Delta.-laurolactone 13.471 C12H22O2 10
34. Decanoic acid Capric acid 13.601 C10H20O2 10
35. 3-Octanol NF 14.002 C10H22O 10
36. Ethyl 3,3-dimethylbutyrate NF 14.246 C8H16O2 1
37. 5-Hexenal NF 14.547 C6H10O 10
38. 2-Pentenoic acid, 4-hydroxy NF 14.878 C5H8O3 10
39. Nonanoic acid, 9-oxo-, methyl ester Azelaadehydic acid 15.065 C10H18O3 10
40. Thiophene, 2-methoxy NF 15.345 C5H6OS 3
41. Octanoic acid, 8-hydroxy NF 15.49 C8H16O3 10
42. Oxirane, octyl NF 15.604 C10H20O 10
43. Butane, 1,1'-oxybis[3-methyl NF 15.875 C10H22O 5
44. 3-Hydroxy-4-methoxystyrene NF 16.153 C9H10O2 7
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Table 3 List of components of essential oil of Rumexhastatus (Continued)
45. Octanoic Acid n-Caprylic acid 16.355 C8H16O2 10
46. 3-Hexanol, 3,5-dimethyl NF 16.55 C8H18O 10
47. 2-Tridecen-1-ol, (E) NF 16.643 C13H26O 10
48. 1-Isopropyl-4,7-dimethyl-1,2-dihydronaphthalene Alpha-Calcorene 16.877 C15H20 10
49. 4-(5',5'-dimethyl-2'-methylidene-3',8'-dioxabicyclo[5.1.0]oct-4-ylidene)-2-b… NF 17.084 C13H18O3 5
50. 9-Methyl-S-octahydrophenanathracene NF 17.192 C15H20 10
51. Z-10-Tetradecen-1-ol acetate NF 17.373 C16H30O2 10
52. Dodecanamide, N,N-bis(2-hydroxyethyl) NF 17.737 C16H33NO3 10
53. 5,8-Dimethyl-1,2,3,4-tetrahydro-1-naphthol NF 17.847 C12H16O 3
54. 3-Hexen-1-ol, benzoate, (Z) NF 17.917 C13H16O2 10
55. Nonanoic acid Pelargic acid 18.014 C9H18O2 10
56. Nonanedioic acid, monomethyl ester NF 18.153 C10H18O4 10
57. (-)-Caryophyllene oxide Caryophyllene oxide 18.311 C15H24O 10
58. (+-)-Andirolactone Andirolactone 18.513 C11H14O2 10
59. Ledol NF 18.64 C15H26O 10
60. (. + -.)-2-Methyl-6-p-tolyl-4-heptanol (diastereoisomer II) NF 18.693 C15H24O 9
61. Propanal, 2,2-dimethyl NF 18.777 C5H10O 1
62. 2,6,10-Trimethylundecan-(5E)-2,5,9-trien-4-one NF 18.869 C14H22O 10
63. 7-oxabicyclo[4.1.0]heptane, 1-(1,3-dimethyl-1,3-butadienyl)-2,2,6-trimethyl- NF 19.004 C15H24O 10
64. Octanoic acid, 6,6-dimethoxy-, methyl ester NF 19.087 C11H22O4 10
65. 2-(p-methylphenyl)-2-nitropropane NF 19.212 C10H13NO2 10
66. Azelaic Acid Anchoic acid 19.589 C9H16O4 4
67. cis-9-oxabicyclo[6.1.0]non-2-ene NF 19.736 C8H12O 10
68. 1-Buten-3-one, 1-(2-carboxy-4,4-dimethylcyclobutenyl) NF 19.864 C11H14O3 10
69. Campherenone Campherenone 20.056 C15H24O 10
70. 11-Hexadecyn-1-ol NF 20.231 C16H30O 10
71. Cyclodecene, 1-ethyl-2-methyl- NF 20.385 C13H24 10
72. 1,3-Dioxolane-4,5-dicarboxylic acid, 2,2-dimethyl-, dimethyl ester NF 20.627 C9H14O6 5
73. 10-(1-Methylallyl)tricyclo[6.3.1.0(2,7)]dodeca-2(7),3,5-trien-10-ol NF 20.768 C16H20O 4
74. 2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin NF 20.894 C15H24O4 10
75. Farnesyl Acetone C Farnesyl Acetone 21.18 C18H30O 10
76. 17-Octadecynoic acid NF 21.401 C18H32O2 10
77. Tetradecanoic acid Myristic acid 21.82 C14H28O2 10
78. Driminol Drimenol 22.167 C15H26O 10
79. 2,2,6-Trimethyl-1-(3-methylbuta-1,3-dienyl)-7-oxabicyclo[4.1.0]heptan-3-ol NF 22.272 C14H22O2 10
80. 1,3,5-trimethyl-6-methyliden-tricyclo[3.2.1.0(2,7)]oct-3-en-8-endo-ol NF 22.677 C12H16O 9
81. 1-Methyl-2-acetyl-6-methoxy-3,4-dihydronaphthalene NF 22.933 C14H16O2 10
82. N-(1-Cyanoethyl)(7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-ylmethanesulfonamide NF 23.386 C13H20N2O3S 10
83. 5-(ethylamino)-1,6-dimethyl-2(1H)-quinolinone NF 23.511 C13H16N2O 10
84. (-)-Isolongifolol Isolongifolol 23.926 C15H26O 10
85. Neophytadiene Neophytadiene 24.02 C20H38 10
86. Naphthalene, 1-(1,1-dimethylethyl)-7-methoxy- NF 24.123 C15H18O 2
87. 2-Pentadecanone, 6,10,14-trimethyl NF 24.218 C18H36O 10
88. 2,5,8-Trimethyltricyclo[5.3.1.1(3,9)]dodecane-2-anti,8-tnti-diol NF 24.561 C15H26O2 3
89. Pentadecanoic acid Pentadecyclic acid 24.74 C15H30O2 10
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90. 9,19-Cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, acetate NF 25.047 C32H52O2 4
91. 8-Keto-10-dehydrobrominated-.beta.-snyderol NF 25.298 C15H22O2 2
92. Widdrol Widdrol 25.848 C15H26O 10
93. 2,4,7,9-Tetramethyl-5-decyne-4,7-diol NF 26.036 C14H26O2 4
94. Phenol, 2-methyl-4-(1,1,3,3-tetramethylbutyl) NF 26.54 C15H24O 10
95. Benzene, 1,1'-(1,2-diethyl-1,2-ethanediyl)bis[4-methoxy- NF 26.548 C20H26O2 10
96. (1R,3S)-2,2,3-Trimethyl-6-methylidenecyclohexane-1-carbaldehyde NF 26.624 C11H18O 5
97. Hexadecanoic acid, methyl ester Methyl palmitate 26.732 C17H34O2 10
98. 1-Hexadecen-3-ol, 3,5,11,15-tetramethyl- NF 27.371 C20H40O 10
99. Benzo[e]isobenzofuran-1,4-dione,1,3,4,5,5a,6,7,8,9,9a-decahydro-6,6,9a-trime… NF 27.585 C15H20O3 10
100. Hexadecanoic acid Palmitic acid 27.984 C16H32O2 10
101. Butane-1,1-dicarbonitrile, 1-cyclohexyl-3-methyl- NF 28.431 C13H20N2 10
102. 2-Methyl-2-propyl-2,5-dihydrofuran NF 28.552 C8H14O 10
103. 5A-Methyl-3,8-dimethylene-2-oxododecahydrooxireno[2',3':6,7]naphtho[1,2-b]fu… NF 28.643 C20H24O5 10
104. 4-(3,7,7-Trimethyl-2-oxabicyclo[3.2.0]hept-3-en-1-yl)but-3-en-2-one NF 28.98 C13H18O2 10
105. Cyclobutanecarboxylic acid, 2-methyloct-5-yn-4-yl ester NF 29.064 C14H22O2 10
106. Cyclooctenone, dimer NF 29.439 C16H24O2 10
107. Undecane, 6-cyclohexyl- NF 29.639 C17H34 10
108. 2,4,5,7-Tetramethyl-2,6-octadiene NF 30.471 C12H22 10
109. Cyclohexane, 1,2,3,4,5,6-hexaethyl NF 30.77 C18H36 10
110. Cyclopentanone, 3-methyl-2-(2-pentenyl)- NF 31.291 C11H18O 10
111. 2-Propanon Acetone 31.44 C3H6O 10
112. beta.-Ionol $$ 3-Buten-2-ol, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- NF 31.703 C13H22O 10
113. Velleral Velleral 32.121 C15H20O2 10
114. 2-Hydrazino-2-imidazoline NF 32.733 C3H8N4 10
115. 2H-cyclopropa[g]benzofuran, 4,5,5A,6,6A,6B-hexahydro-4,4,6b-trimethyl-2-(1-m… NF 33.658 C15H22O 10
116. Hexadecane Cetane 37.132 C16H34 10
117. Docosane Docosane 38.808 C22H46 10
118. 4,4-6-Trimethyl-7-oxabicyclo[4.1.0]heptan-2-one NF 39.247 C9H14O2 10
119. 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester NF 39.623 C24H38O4 10
120. 4-Allyl-1-ethoxy-3-phenylbenzo[c]-(1,2)-oxaphosphinine - 1-Oxide NF 40.4 C19H19O3P 3
121. Hexadecane Cetane 41.915 C16H34 10
122. Undecane, 3,8-dimethyl- NF 44.76 C13H28 10
123. 4-Methyl-7-ethylizidine $$ 8-Methyl-5-ethylindolizidine NF 58.237 C11H21N 10
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of DPPH solution. The mixture obtained was incu-
bated at 23 °C for 30 min in dark. After incubation
the absorbance of each sample were recorded at the
wavelength of 517 nm using double beam spectropho-
tometer. Ascorbic acid was used as positive control.
All the samples were processed in triplicates and the
percent activity was recorded as mean ± SEM. The
percent radical scavenging potential was figured out
using the following formula;% scavenging ¼ absorption of control−absorption of test sample
absorption of control
100
ABTS radical scavenging assay
The 2, 2-azinobis [3-ethylbenzthiazoline]-6-sulfonic acid
(ABTS) free radicals scavenging assay of the essential oil
was evaluated followed standard procedure [11]. ABTS
solution 7 mM and potassium persulfate solution
2.45 mM were prepared and mixed thoroughly. The
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Fig. 1 Antioxidant potential of essential of Rumex hastatus against
DPPH and ABTS
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duction of free radicals. After incubation time the ab-
sorbance of solution was adjusted at 745 nm to 0.7 by
the addition of 50 % methanol. Test samples having vol-
ume of 300 μl was taken in a test tube and 3 mL ABTS
solution was added to it. The solution was transferred to







































































Fig. 2 a. Regression and correlation of percent BChE inhibition of essential
inhibition of essential oil Vs Galanthamineminutes using double beam spectrophotometer. Ascor-
bic acid was used as positive control. All the samples
were run in triplicate and percent ABTS radical scaven-
ging potential was figured out using the following
formula;
% scavenging activity ¼ control absorbance−sample absorbance
control absorbance
100
Estimation of IC50 values
The median inhibitory concentration i.e., IC50 values of
AChE, BChE, DPPH and ABTS were determined by a
linear regression analysis of the percent inhibition versus
the concentrations of test samples through MS Excel
program.
Statistical data analysis
All the tests were conducted in triplicate and the values
were tabulated as mean ± S.E.M. Significant difference of
the percent inhibition of various test samples was ana-
lyzed via two way ANOVA following Bonferroni’s post
test using GraphPad Prism software in which the P < 0.05
were considered significant.1x + 22.69
0.988
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Fig. 3 Structures of some important components of essential oil of Rumex hastatus
Ahmad et al. BMC Complementary and Alternative Medicine  (2016) 16:29 Page 8 of 11Results and discussion
In the current investigational study the radical scaven-
ging potential of volatile oil was studied based on spec-
trophotometric analysis. The sources of free radicals
employed were DPPH and ABTS, which have maximum
absorbance values at 517 nm and 745 nm respectively.
After getting scavenged by antioxidant compounds the
colors of DPPH (violet) and ABTS (blue) solution
change into yellow. Change in the color results in de-
crease of absorbance values which is directly propor-
tional to the amount of radical scavenging compounds
in the solution [32, 33].
Similarly, the anticholinesterase activity is based on
the hydrolysis of acetylthiocholine iodide and butyryl-
choline iodide by the formation of the yellow 5-thio-2-
nitrobenzoate anion as a result of the reaction of DTNB
with thiocholines, catalyzed by enzymes at a wavelength
of 412 nm using spectrophotometer or microplate
reader. Acetylthiocholine iodide and butyrylthiocholine
iodide work as substrate of the reaction, while the
DTNB is utilized for the measurement of cholinesterase
activity. The percent inhibition of enzymatic activity is
calculated from the rate of change in absorption of the
reaction mixture [34].
The available literature on etiology of diseases demon-
strate multiple causative agents responsible for specificdisease [35]. In the context of Alzheimer’s disease, nu-
merous investigators have reported the role of various
causative agents along with various successful ap-
proaches [36]. Like all neurodegenerative disorders, the
free radicals have a prominent role in the induction and
progression of AD [37]. By avoiding or attenuating the
causative agents one can hinder the progression of a
specific disease. In case of neurodegenerative disorders,
the scavenging of free radicals can be a vital target. Vari-
ous researchers have demonstrated the effective role of
natural antioxidants especially the essential oils to com-
bat the free radicals [38]. Similarly, one of the most
widely employed treatment strategies for AD i.e., the in-
hibition of AChE to increase the concentration of neuro-
transmitter is highly recommended [39]. In this regard,
essential oils are being investigated by advanced re-
searchers with better results. Essential oils obtained from
various plants possess marked anti-Alzheimer’s potential
due to the presence of wide variety of valuable com-
pounds in it [40, 41]. The anticholinesterase potential of
essential oil of Rumex hastatus has been summarized in
the Table 1, while the Table 2 shows various parameters
of the compounds present in the essential oil of this
plant. The GC-MS analysis of essential oil of R. hastatus
demonstrates a total of 123 components as shown in
Table 3. The anticholinesterase activity of essential oil of
Fig. 4 GC-MS Chromatogram of essential oil of Rumex hastatus
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cause of the good affinity of hydrophobic active site of
AChE [42, 43]. Some of the most common components
of essential oils i.e., palmitic acid, myristic acid, pelargic
acid, capric acid, docosane, cetane, velleral, acetone, me-
thyl palmitate, widdrol, isolongifolol, ophytadiene, dri-
menol and levulinic acid have been found in the
essential oil of R. hastatus. Some of these components
have been reported previously by other investigators to
possess antioxidant and anticholinesterase potentials
[44–49]. The percent antioxidant potential of essential
oil is illustrated in the Fig. 1. The peaks given in the
Table 2 shows various volatile compounds like 5-ethyl-
2(5H)-furanone, trimethylacetic anhydride, cycloocta-
none, 5-methyl-3-heptanol, methyl 2-vinylbutanoate, 2-
(p-methylphenyl)-2-nitropropne, azelaaldehydic acid,
2,4,6-trimethyloctane and trans-3-nonen-2-one with re-
tention times of 6.447, 6.818, 10.958, 11.363, 11.761,
12.97, 13.171, 13.308, 15.063 and 19.213 min respect-
ively. Going to the detail of various components of es-
sential oil of R. hastatus, it is clear that the marked
anticholinesterase potential shown by essential oil is ob-
served due to the presence of wide variety of compounds
in it. Essential oil demonstrated 74.90, 71.70, 67.26,
61.64, 54.32 % AChE inhibition at 1000, 500, 250, 125,
62.5 μg/ml respectively. Similarly, the BChE inhibition
exhibited by essential oil was recorded as 71.32, 66.33,
46.32, 52.73, 57.00 % at 1000, 500, 250, 125, 62.5 μg/ml
respectively. The essential oil attain IC50 values of 32.54
and 97.38 μg/ml for AChE and BChE inhibitions re-
spectively. The anticholinesterase potential shown by es-
sential oil goes parallel with the positive control which is
also obvious from the Fig. 2 (a & b) with the correlation
coefficient of 0.961 and 0.988 for essential oil versus
AChE and BChE respectively. Apart from theanticholinesterase potential of essential oil, the antioxi-
dant potential of essential oil of various plants has been
reported with discrimination by various investigators
[50, 51]. In our current investigational study, the free
radicals scavenging assay of essential oil of R. hastatus
against DPPH and ABTS was significant and almost
comparable with the positive control. From Fig. 1, it is
clear that essential oil exhibited marked potential with
IC50 of 3.71 and 6.29 μg/ml against DPPH and ABTS re-
spectively, which is also comparable with the previously
reported literature. The previously reported data of R.
hastatus verifies its anticholinesterase and antioxidant
potentials which may be linked to the current investiga-
tional studies [26]. Some important components of
essential oil and the chromatogram have been given in
Figs. 3 and 4 respectively.Conclusion
Essential oil isolated for the first time from the R. hasta-
tus and its chemical composition demonstrates that R.
hastatus is a source of valuable volatile components.
Based on the anticholinesterase and antioxidant results
of essential oil, it can be concluded that R. hastatus
plant may be an effective source of compounds which
may lead to possible palliative therapy and cure of oxida-
tive stresses and neurodegenerative diseases.Competing interests
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